The US FDA is currently reviewing its pharmaceutical manufacturing Guidance, after receiving feedback from industry trade groups. What will the new Guidance mean for pharma companies, as well as ...
The United States Food and Drug Administration (FDA) recently released a draft guidance, Expedited Program for Serious ...
In January 2025, various US Food and Drug Administration (FDA) centers and offices published their guidance agendas for the 2025 calendar year ...
On January 6, 2025, the US Food and Drug Administration (FDA) published final guidance titled “Communications From Firms to Health Care ...
U.S. President Donald Trump is set to meet with top pharmaceutical executives on Thursday, a White House official confirmed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback